|
Phase 1 study on safety and PK of rovalpituzumab tesirine (Rova-T) in Japanese patients with advanced, recurrent SCLC |
|
|
|
Titel: |
Phase 1 study on safety and PK of rovalpituzumab tesirine (Rova-T) in Japanese patients with advanced, recurrent SCLC |
Auteur: |
Tanaka, Kentaro Udagawa, Hibiki Akamatsu, Hiroaki Takeda, Masayuki Kanda, Shintaro Yasuda, Ikuko Okubo, Sumiko Wong, Shekman Scripture, Charity Tamura, Tomohide Okamoto, Isamu |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 29 () nr. S7 pagina's vii57 |
Jaar: |
2018 |
Inhoud: |
|
Uitgever: |
THE AUTHORS |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|